metricas
covid
Buscar en
Cirugía Española
Toda la web
Inicio Cirugía Española Linfomas no hodgkinianos B del timo
Información de la revista
Vol. 71. Núm. 5.
Páginas 239-243 (mayo 2002)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 71. Núm. 5.
Páginas 239-243 (mayo 2002)
Acceso a texto completo
Linfomas no hodgkinianos B del timo
Thymic non-hodgkin’s B-cell lymphomas
Visitas
8953
A. Ríos1
Autor para correspondencia
arzrios@teleline.es

Correspondencia: Dr. A. Ríos Zambudio. Avenida de la Libertad, 208. 30007 Casillas. Murcia. España.
, P.J. Galindo, J. Torres, M.J. Roca, P. Parrilla
Departamento de Cirugía. Servicio de Cirugía Torácica.
A. Sáncheza, L.A. Polob, J. Solab, J.L. Alonsoc
a Unidad de Cuidados Intensivos.
b Servicio de Anatomía Patológica.
c Servicio de Oncología. Hospital Universitario Virgen de la Arrixaca. El Palmar. Murcia. España.
Este artículo ha recibido
Información del artículo
Resumen
Bibliografía
Descargar PDF
Estadísticas
Resumen
Introducción

Los linfomas tímicos no hodgkinianos son infrecuentes y se originan en células T. Sin embargo, en las últimas décadas se ha identificado uno con origen en las células B, el linfoma primario mediastínico B (LPMB). Presentamos nuestra experiencia y analizamos el manejo diagnóstico-terapéutico de estos linfomas.

Pacientes y método

Se han revisado todos los LPMB, siendo las variables a estudio el sexo, la edad, el tiempo de evolución, la sintomatología, las exploraciones diagnósticas, la estadificación, el tratamiento y la evolución.

Resultados

Se detectaron 3 casos, con una edad inferior a los 30 años, que consultaron principalmente por dolor torácico y disnea. Todos presentaban derrame pleural y dos pericárdico, uno de ellos severo. En un caso se presentó un síndrome de vena cava superior En 2 casos se realizó una mediastinotomía diagnóstica y en uno una timectomía por sospecha de timoma. Los pacientes fueron tratados con radioterapia, 50 Gy, y quimioterapia (MACOP-B en dos y CHOP en uno). Dos pacientes han presentado recidiva antes del año de evolución.

Conclusiones

El LPMB afecta a la población joven y es muy agresivo, con un elevado índice de recidivas precoces a pesar de un tratamiento agresivo con radioterapia y poliquimioterapia.

Palabras clave:
Linfoma no hodgkiniano
Linfoma primario mediastínico de células B
Variedad esclerosante
Quimioterapia
Cirugía
Radioterapia
Timo
Introduction

Thymic non-Hodgkin’s lymphomas are rare and originate in T-cells. However, in the last few decades, a lymphoma originating in B-cells has been identified: primary mediastinal B-cell lymphoma (PMBL). We present our experience and analyze the diagnostic and therapeutic approach to these lymphomas.

Patients and method

We reviewed all cases of PMBL. The variables studied were sex, age, time from onset, symptomatology, diagnostic investigations, staging, treatment and outcome.

Results

Three cases were detected. The patients were aged less than 30 years and sought medical care mainly for chest pain and dyspnea. All three patients presented pleural effusions and two presented pericardiac effusion, which was severe in one. One patient presented superior vena cava syndrome. Diagnostic mediastinotomy was performed in two patients and thymectomy was performed in one for suspected thymoma. Treatment consisted of radiotherapy (50 Gy) and chemotherapy (MACOP-B in two patients and CHOP in one). Recurrence occurred in two patients within 1 year of follow-up.

Conclusions

PMBL affects the young and is highly aggressive with a high rate of early recurrences despite radiotherapy and polychemotherapy.

Key words:
Non-Hodgkin’s lymphoma
Primary mediastinal B-cell lymphoma
Sclerosis type
Chemotherapy
Surgery
Radiotherapy
Thymus
El Texto completo está disponible en PDF
Bibliografía
[1.]
D.C. Strollo, M.L. Rosado de Christenson.
Tumors of the thymus.
J Thorac Imaging, 14 (1999), pp. 152-171
[2.]
P.G. Isaacson, A.J. Norton, B.J. Addis.
The human thymus contains a novel population of B lymphocytes.
Lancet, 2 (1987), pp. 1488-1490
[3.]
M. Lazzarino, E. Orlandi, M. Paulli, J. Sträter, C. Klersy, U. Gianelli.
Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients.
J Clin Oncol, 15 (1997), pp. 1646-1653
[4.]
J. Sánchez Fayos, A. Roman, M.I. Nevado.
Linfoma mediastínico B —¿tímico?— de célula grande. Una entidad anatomoclínica en gestación.
An Med Intern (Madrid), 13 (1996), pp. 37-39
[5.]
N.L. Harris, E.S. Jaffe, H. Stein, P.M. Banks, J.K. Chan, M.L. Cleary.
A Revised European American classification for lymphoid neoplasms: a proposal from the International Lymphoma Study Group.
Blood, 84 (1994), pp. 1361-1392
[6.]
K. Van Besien, M. Kelta, P. Bahaguna.
Primary mediastinal B cell lymphoma: a review of pathology and management.
J Clin Oncol, 19 (2001), pp. 1855-1864
[7.]
D. Kirn, P. Mauch, K. Shaffer, G. Pinkus, M.A. Shipp, W.D. Kaplan.
Large cell and immunoblastic lymphoma of the mediastinum: prognostic features and treatment outcome in 57 patients.
J Clin Oncol, 11 (1993), pp. 1336-1343
[8.]
M. Lazzarino, E. Orlandi, M. Paulli, E. Boveri, E. Morra, E. Brusamolino.
Primary mediastinal B cell lymphoma with sclerosis: an aggressive tumor with distinctive clinical and pathologic features.
J Clin Oncol, 11 (1993), pp. 2306-2313
[9.]
P.C. Bishop, W.H. Wilson, D. Pearson, J. Janik, E.S. Jaffe, P.C. Elwood.
CNS involvement in primary mediastinal large B-cell lymphoma.
J Clin Oncol, 17 (1999), pp. 2479-2485
[10.]
S.Z. Ali, Y.S. Erozan.
Thymoma: the cytopathologic features and differential diagnosis on fine needle aspiration.
Acta Cytol, 42 (1998), pp. 845-854
[11.]
J. García Conde, M.J. Terol, I. Benet.
Síndrome de vena cava superior por linfoma B de células grandes de origen tímico y de la localización mediastínica.
An Med Intern (Madrid), 14 (1997), pp. 82-83
[12.]
A.A. Abou-Elella, D.D. Weisenburger, J.M. Vose, J.P. Kollath, J.C. Lynch, M.A. Bast.
Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 43 patients from the Nebraska Lymphoma Study Group.
J Clin Oncol, 17 (1999), pp. 784-790
[13.]
B. Falini, S. Venturi, M. Martelli, A. Santucci, S. Pileri, E. Pescarmona.
Mediastinal large B cell lymphoma: clinical and immunohistological findings in 18 patients treated with different third generation regimens.
Br J Haematol, 89 (1995), pp. 780-789
[14.]
A.A. Alizadeh, M.B. Eisen, R.E. Davis, C. Ma, I.S. Lossos, A. Rosenwald.
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.
Nature, 403 (2000), pp. 503-511
[15.]
P. Moller, G. Moldenhauer, F. Momburg, B. Lammler, M. Eberlein-Gonska, S. Kiesel.
Mediastinal lymphoma of clear cell type is a tumor corresponding to terminal steps of B cell differentiation.
Blood, 69 (1987), pp. 1087-1095
[16.]
J.O. Jacobson, A.C. Aisenberg, L. Lamarre, C.G. Villett, N.L. Harris.
Mediastinal large cell lymphoma. An uncommon subset of adult lymphoma curable with combined modality therapy.
Cancer, 62 (1988), pp. 1993-1998
[17.]
P.L. Zinzani, M. Martelli, M. Bendandi, A. De Renzo, A. Zaccaria, E. Pavone.
Primary mediastinal large B cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy.
Haematologica, 86 (2001), pp. 187-191
[18.]
L.N. Nguyen, C.S. Ha, M. Hess, J.E. Romaguera, J.T. Manning, F. Cabanillas.
The outcome of combined modality treatments for stage I and II primary large B cell lymphoma of the mediastinum.
Int J Radiat Oncol Biol Phys, 47 (2000), pp. 1281-1285
[19.]
L.H. Sehn, J.H. Antin, L.N. Shulman, P. Mauch, A. Elias, M.E. Kadin.
Primary diffuse large B-cell lymphoma of the mediastinum: outcome following high-dose chemotherapy and autologous hematopoietic cell transplantation.
Blood, 91 (1998), pp. 717-723
[20.]
A. Nademanee, A. Molina, M.R. O’Donnell, A. Dagis, D.S. Snyder, P. Parker.
Results of high-dose therapy and autologous bone marrow/ stem cell transplantation during remission in poor-risk intermediate-and high-grade lymphoma: international index high and high-intermediate risk group.
Blood, 90 (1997), pp. 3844-3852
[21.]
A.Z.S. Rohatiner, J.S. Whelan, R.K. Ganjoo, A.J. Norton, A. Wilson, T.A. Lister.
Mediastinal large cell lymphoma with sclerosis (MLCLS)O.
Br J Cancer, 69 (1994), pp. 601-604
[22.]
D. Cazals Hatem, E. Lepage, P. Brice, A. Ferrant, M.F. d’Agay, E. Baumelou.
Primary mediastinal large B cell lymphoma. A clinicopathologic study of 141 cases compared wtih 916 non mediastinal large B cell lymphomas, a GELA (“Groupe d’Etude des Lymphomes de l’Adulte”) study.
Am J Surg Pathol, 20 (1996), pp. 877-888
[23.]
A.S. Spiers, J.E. Husband, A.D. MacVicar.
Treated thymic lymphoma: comparison of MR imaging with CT.
Radiology, 203 (1997), pp. 369-376
[24.]
M.P. Martelli, M. Martelli, E. Pescarmona, V. De Sanctis, V. Donato, F. Palombi.
MACOP-B and involved field radiation therapy is an effective therapy for primary mediastinal large B-cell lymphoma with sclerosis.
Ann Oncol, 9 (1998), pp. 1027-1029
[25.]
P.L. Zinzani, M. Martelli, M. Magagnoli, E. Pescarmona, L. Scaramucci, F. Palombi.
Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by (67) gallium scan in 50 patients.
Blood, 94 (1999), pp. 3289-3293
Copyright © 2002. Asociación Española de Cirujanos
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.ciresp.2024.05.014
No mostrar más